Fasting Before Contrast-Enhanced CT May Not Be Necessary for Some Patients
The number of adverse events related to contrast-enhanced CT are not statistically different between patients who fasted or who ate beforehand.
It may not be necessary for cancer patients to fast prior to undergoing contrast-enhanced CT, according to a study published in the American Journal of Roentgenology.
Researchers from Brazil performed a prospective study to evaluate the effects of preparative fasting prior to contrast-enhanced CTs for patients with cancer. A total of 3,206 patients were randomly assigned to one of two groups; 1,619 fasted for at least 4 hours prior to their procedure and 1,587 consumed a light meal before undergoing the scan.
The results showed 45 patients (1.5 percent) in the fasting group reported adverse events, compared with 30 patients (0.9 percent) in the non-fasting group. The most common adverse events were:
• Nausea: 32 patients
• Weakness: 12 patients
• Vomiting: 5 patients
The authors noted that the frequency of symptoms between the two groups did not differ statistically significantly.
They concluded that among their sample group, there were few adverse reactions associated with eating a light meal before undergoing a CT scan with an IV contrast agent. “These results support the idea that preparation for contrast-enhanced CT can be simplified, decreasing the discomfort and inconvenience experienced by patients,” they wrote.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
